Skip to content

Implementation of a cost effective strategy to prevent neonatal infection by group B-hemolytic streptococcus

Implementation of a cost effective strategy to prevent neonatal infection by group B-hemolytic streptococcus - GBS implementation study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37307
Enrollment
1260
Registered
2012-12-12
Start date
2013-03-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early onset group B streptococcus disease

Interventions

None listed

Sponsors

TNO
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Midwives, gynecologists and pediatricians working in one hospital and the region around this hospital. All pregnant women in care of the midwive or gynecologist in the hospital region from pregnancy week 30 onwards.

Exclusion criteria

Exclusion criteria: Pregnant women who refuse the 'new' policy of GBS prevention are offered the care as usual.

Design outcomes

Primary

MeasureTime frame
Percentage adherence to the different prevention strategies compared with the percentage adherence to the current Dutch guideline.

Secondary

MeasureTime frame
Adherence of the prevention strategies, clinical and process outcomes, cost effectiveness analysis of the different prevention strategies, experiences of pregnant women and care providers.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)